Oxidative stress, inflammation, and neuroprogression in chronic PTSD

Harvard Review of Psychiatry

Volumn 26, Issue 2, 2018, Pages 57-69

  Miller, Mark W ^a,b   Lin, Alex P ^c   Wolf, Erika J ^a,b   Miller, Danielle R ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Accelerated aging; Inflammation; Magnetic resonance spectroscopy; Neurodegeneration; Neuroprogression; Oxidative stress; Posttraumatic stress disorder

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; C REACTIVE PROTEIN;

AGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DRUG TARGETING; HUMAN; IN VIVO STUDY; INFLAMMATION; NERVE DEGENERATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; BRAIN; CHRONIC DISEASE; DIAGNOSTIC IMAGING; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BRAIN; CHRONIC DISEASE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85044213318     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000167     Document Type: Review

References (136)

1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048–60.
2. Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 2000;61 suppl 5: 4–12; discussion 13–4.
3. Solomon SD, Davidson JR. Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry 1997;58 suppl 9:5–11.
4. Wolf EJ, Schnurr PP. PTSD-related cardiovascular disease and accelerated cellular aging. Psychiatr Ann 2016;46:527–32.
5. Burri A, Maercker A, Krammer S, Simmen-Janevska K. Childhood trauma and PTSD symptoms increase the risk of cognitive impairment in a sample of former indentured child laborers in old age. PLoS One 2013;8:e57826.
6. Yaffe K, Vittinghoff E, Lindquist K, et al. Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry 2010;67:608–13.
7. Miller MW, Sadeh N. Traumatic stress, oxidative stress and posttraumatic stress disorder: neurodegeneration and the acceleratedaging hypothesis. Mol Psychiatry 2014;19:1156–62.
8. Miller MW, Wolf EJ, Sadeh N, et al. A novel locus in the oxidative stress-related gene ALOX12 moderates the association between PTSD and thickness of the prefrontal cortex. Psychoneuroendocrinology 2015;62:359–65.
9. Aquilano K, Baldelli S, Ciriolo MR. Glutathione: new roles in redox signaling for an old antioxidant. Front Pharmacol 2014;5:196.
10. Schiavone S, Jaquet V, Trabace L, Krause KH. Severe life stress and oxidative stress in the brain: fromanimalmodels to human pathology. Antioxid Redox Signal 2013;18:1475–90.
11. Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65–74.
12. Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev 2016;2016:e569831.
13. Attari A, Asgary S, Naderi G, Rezayat A. Lipid peroxidation and antioxidant capacity in posttraumatic stress disorder. J Isfahan Med Sch 2002;20:4–6.
14. Tezcan E, Atmaca M, Kuloglu M, Ustundag B. Free radicals in patients with post-traumatic stress disorder. Eur Arch Psychiatry Clin Neurosci 2003;253:89–91.
15. Zieker J, Zieker D, Jatzko A, et al. Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry 2007;12:116–8.
16. Čeprnja M, Derek L, Unic A, et al. Oxidative stress markers in patients with post-traumatic stress disorder. Coll Antropol 2011;35:1155–60.
17. Glatt SJ, Tylee DS, Chandler SD, et al. Blood-based geneexpression predictors of PTSD risk and resilience among deployed marines: a pilot study. Am J Med Genet B Neuropsychiatr Genet 2013;162B:313–26.
18. Tylee DS, Chandler SD, Nievergelt CM, et al. Blood-based geneexpression biomarkers of post-traumatic stress disorder among deployed marines: a pilot study. Psychoneuroendocrinology 2015;51:472–94.
19. Michels L, Schulte-Vels T, Schick M, et al. Prefrontal GABA and glutathione imbalance in posttraumatic stress disorder: preliminary findings. Psychiatry Res 2014;224:288–95.
20. Borovac Štefanović L, Kalinić D, Mimica N, et al. Oxidative status and the severity of clinical symptoms in patients with posttraumatic stress disorder. Ann Clin Biochem 2015;52:95–104.
21. Atli A, Bulut M, Bez Y, et al. Altered lipid peroxidation markers are related to post-traumatic stress disorder (PTSD) and not trauma itself in earthquake survivors. Eur Arch Psychiatry Clin Neurosci 2016;266:329–36.
22. Şimşek Ş, Yuksel T, Kaplan I, Uysal C, Aktas H. The levels of cortisol and oxidative stress and DNA damage in child and adolescent victims of sexual abuse with or without post-traumatic stress disorder. Psychiatry Investig 2016;13:616–21.
23. Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2'- deoxyguanosine in clinical depression. Psychosom Med 2006; 68:1–7.
24. Irie M, Asami S, Ikeda M, Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun 2003;311:1014–8.
25. Bulut M, Selek S, Bez Y, et al. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder. J Affect Disord 2013;150:829–33.
26. Ozdemir O, Selvi Y, Ozkol H, Tuluce Y, Besiroglu L, Aydin A. Comparison of superoxide dismutase, glutathione peroxidase and adenosine deaminase activities between respiratory and nocturnal subtypes of patients with panic disorder. Neuropsychobiology 2012;66:244–51.
27. Logue MW, Bauver SR, Knowles JA, et al. Multivariate analysis of anxiety disorders yields further evidence of linkage to chromosomes 4q21 and 7p in panic disorder families. Am J Med Genet B Neuropsychiatr Genet 2012 Apr;159B: 274–80.
28. Amstadter AB, Sumner JA, Acierno R, et al. Support for association of RORAvariant and posttraumatic stress symptoms in a population-based study of hurricane exposed adults. Mol Psychiatry 2013;18:1148–9.
29. Miller MW, Wolf EJ, Logue MW, Baldwin CT. The retinoidrelated orphan receptor alpha (RORA) gene and fear-related psychopathology. J Affect Disord 2013;151:702–8.
30. Lowe SR, Meyers JL, Galea S, et al. RORA and posttraumatic stress trajectories:main effects and interactions with childhood physical abuse history. Brain Behav 2015;5:e00323.
31. Pallast S, Arai K, Wang X, Lo EH, van Leyen K. 12/15- Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem 2009;111:882–9.
32. Passos IC, Vasconcelos-Moreno MP, Costa LG, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2015;2:1002–12.
33. Pollard HB, Shivakumar C, Starr J, et al. “Soldier’s heart”: a genetic basis for elevated cardiovascular disease risk associated with post-traumatic stress disorder. Front Mol Neurosci 2016;9:87.
34. Breen MS, Maihofer AX, Glatt SJ, et al. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol Psychiatry 2015;20:1538–45.
35. Smith AK, Conneely KN, Kilaru V, et al. Differential immune system DNA methylation and cytokine regulation in posttraumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2011;156B:700–8.
36. Di Napoli M, Godoy DA, Campi V, et al. C-reactive protein in intracerebral hemorrhage: time course, tissue localization, and prognosis. Neurology 2012;79:690–9.
37. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease. Brain Res 2000;887:80–9.
38. Strang F, Scheichl A, Chen YC, et al. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer’s disease? Brain Pathol 2012;22:337–46.
39. Alexandrov PN, Kruck TP, Lukiw WJ. Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein (CRP) in human brain microvessal endothelial cells (hBMECs). J Inorg Biochem 2015;152:210–3.
40. Elwood E, Lim Z, Naveed H, Galea I. The effect of systemic inflammation on human brain barrier function. Brain Behav Immun 2017;62:35–40.
41. Kuhlmann CR, Librizzi L, Closhen D, et al. Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke 2009;40:1458–66.
42. Miller RJ, Sutherland AG, Hutchinson JD, Alexander DA. C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine 2001;13:253–5.
43. Sőndergaard HP, Hansson LO, Theorell T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta 2004;342:93–8.
44. von Känel R, Hepp U, Kraemer B, et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007;41:744–52.
45. Spitzer C, Barnow S, Völzke H, et al. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J Psychiatr Res 2010;44:15–21.
46. von Känel R, Begre S, Abbas CC, Saner H, Gander ML, Schmid JP. Inflammatory biomarkers in patientswith posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation 2010; 17:39–46.
47. McCanlies EC, Araia SK, Joseph PN. C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine 2011;55:74–8.
48. Muhtz C, Godemann K, von Alm C, et al. Effects of chronic posttraumatic stress disorder on metabolic risk, quality of life, and stress hormones in aging former refugee children. J Nerv Ment Dis 2011;199:646–52.
49. Gill J, Saligan L, Lee H, Rotolo S, Szanton S.Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls. J Psychosom Res 2013;74:301–6.
50. Plantinga L, Bremner JD, Miller AH, et al. Association between posttraumatic stress disorder and inflammation: a twin study. Brain Behav Immun 2013;30:125–32.
51. Heath NM, Chesney SA, Gerhart JI, et al. Interpersonal violence, PTSD, and inflammation: potential psychogenic pathways to higher C-reactive protein levels. Cytokine 2013;63:172–8.
52. Baumert J, Lukaschek K, Kruse J, et al. No evidence for an association of posttraumatic stress disorder with circulating levels of CRP and IL-18 in a population-based study. Cytokine 2013;63:201–8.
53. Eraly SA, Nievergelt CM, Maihofer AX, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014;71:423–31.
54. Lindqvist D, Wolkowitz OM, Mellon S, et al. Pro-inflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav Immun 2014;42:81–8.
55. Michopoulos V, Rothbaum AO, Jovanovic T, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. AmJ Psychiatry 2015;172:353–62.
56. Bersani FS, Wolkowitz OM, Lindqvist D, et al. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain Behav Immun 2016;52: 153–60.
57. Dennis PA, Weinberg JB, Calhoun PS, et al. An investigation of vago-regulatory and health-behavior accounts for increased inflammation in posttraumatic stress disorder. J Psychosom Res 2016;83:33–9.
58. Rosen RI, Levy-Carrick N, Reibman J, et al. Elevated C-reactive protein and posttraumatic stress pathology among survivors of the 9/11 World Trade Center attacks. J Psychiatr Res 2017;89:14–21.
59. Dupuis J, Larson MG, Vasan RS, et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 2005;182:307–14.
60. Pankow JS, Folsom AR, Cushman M, et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001;154:681–9.
61. Retterstol L, Eikvar L, Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 2003;169:279–82.
62. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897–908.
63. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57: 925–35.
64. Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 2012;1261:55–63.
65. Costantini D, Marasco V, Møller AP. A meta-analysis of glucocorticoids as modulators of oxidative stress in vertebrates. J Comp Physiol B 2011;181:447–56.
66. Sato H, Takahashi T, Sumitani K, Takatsu H, Urano S. Glucocorticoid generates ROS to induce oxidative injury in the hippocampus, leading to impairment of cognitive function of rats. J Clin Biochem Nutr 2010;47:224–32.
67. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012;37:137–62.
68. Sapolsky RM, Romero LM, Munk AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr Rev 2000;21:55–89.
69. MacPherson A, Dinkel K, Sapolsky R. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Exp Neurol 2005;194:376–83.
70. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 2005;25: 9275–84.
71. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 2003;100:13632–7.
72. Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 2017;42:254–70.
73. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342:373–7.
74. Alzoubi KH, Khabour OF, Salah HA, Abu Rashid BE. The combined effect of sleep deprivation and Western diet on spatial learning and memory: role of BDNF and oxidative stress. J Mol Neurosci 2013;50:124–33.
75. Gulec M, Ozkol H, Selvi Y, et al. Oxidative stress in patients with primary insomnia. Prog Neuropsychopharmacol Biol Psychiatry 2012;37:247–51.
76. Vollert C, Zagaar M, Hovatta I, et al. Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behav Brain Res 2011; 224:233–40.
77. Silva RH, Abilio VC, Takatsu AL, et al. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 2004;46:895–903.
78. Hurtado-Alvarado G, Pavón L, Castillo-García SA, et al. Sleep loss as a factor to induce cellular and molecular inflammatory variations. Clin Dev Immunol 2013;2013:018341.
79. Hurtado-Alvarado G, Dominquez-Salazar E, Pavon L, Velazquez-Moctezuma J, Gomez-Gonzalez B. Blood-brain barrier disruption induced by chronic sleep loss: low-grade inflammation may be the link. J Immunol Res 2016;2016:4576012.
80. Livingston WS, Rusch HL, Nersesian PV, Baxter T, Mysliwiec V, Gill JM. Improved sleep in military personnel is associated with changes in the expression of inflammatory genes and improvement in depression symptoms. Front Psychiatry 2015;6:59.
81. Kühn S, Gallinat J. Gray matter correlates of posttraumatic stress disorder: a quantitative meta-analysis. Biol Psychiatry 2013;73:70–4.
82. O’Doherty DC, Chitty KM, Saddiqui S, Bennett MR, Lagopoulos J. A systematic review and meta-analysis of magnetic resonance imaging measurement of structural volumes in posttraumatic stress disorder. Psychiatry Res 2015;232:1–33.
83. Wolf EJ, Logue MW, Hayes JP, et al. AcceleratedDNAmethylation age: associations with PTSD and neural integrity. Psychoneuroendocrinology 2016;63:155–62.
84. Marioni RE, Shah S, McRae AF, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 2015;16:25.
85. Karl A, Werner A. The use of proton magnetic resonance spectroscopy in PTSD research—meta-analyses of findings and methodological review. Neurosci Biobehav Rev 2010;34:7–22.
86. Freeman TW, Cardwell D, Karson CN, Komoroski RA. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 1998;40:66–71.
87. De Bellis MD, Keshavan MS, Spencer S, Hall J. NAcetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. Am J Psychiatry 2000;157:1175–7.
88. Schuff N, Neylan TC, Lenoci MA, et al. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 2001;50:952–9.
89. Neylan TC, Schuff N, Lenoci M, Yehuda R, Weiner MW, Marmar CR. Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 2003;54:1118–21.
90. Villareal G, Petropoulos H, Hamilton DA, et al. Proton magnetic resonance spectroscopy of the hippocampus and occipital white matter in PTSD: preliminary results. Can J Psychiatry 2002;47:666–70.
91. Lim MK, Suh CH, Kim HJ, et al. Fire-related post-traumatic stress disorder: brain 1H-MR spectroscopic findings. Korean J Radiol 2003;4:79–84.
92. Brown S, Freeman T, Kimbrell T, Cardwell D, Komoroski R. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of former prisoners of war with and without posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 2003;15:367–70.
93. Menon M, Nasrallah H, Lyons J, Scott M, Liberto V. Singlevoxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry Res 2003;123:101–8.
94. Seedat S, Videen JS, Kennedy CM, Stein MB. Single voxel protonmagnetic resonance spectroscopy in women with and without intimate partner violence-related posttraumatic stress disorder. Psychiatry Res 2005;139:249–58.
95. Kimbrell T, Leulf C, Cardwell D, Komoroski RA, Freeman TW. Relationship of in vivo medial temporal lobe magnetic resonance spectroscopy to documented combat exposure in veterans with chronic posttraumatic stress disorder. Psychiatry Res 2005; 140:91–4.
96. Mahmutyazicioğlu K, Konuk N, Ozdemir H, Atasoy N, Atik L, Gündoğdu S. Evaluation of the hippocampus and the anterior cingulate gyrus by proton MR spectroscopy in patients with post-traumatic stress disorder. Diagn Interv Radiol 2005;11:125–9.
97. Freeman T, Kimbrell T, Booe L, et al. Evidence of resilience: neuroimaging in former prisoners of war. Psychiatry Res 2006;146:59–64.
98. Li L, Chen S, Liu J, Zhang J, He Z, Lin X. Magnetic resonance imaging and magnetic resonance spectroscopy study of deficits in hippocampal structure in fire victims with recent-onset posttraumatic stress disorder. Can J Psychiatry 2006;51:431–7.
99. Ham BJ, Chey J, Yoon SJ, et al. Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: a proton magnetic resonance spectroscopy study. Eur J Neurosci 2007;25:324–9.
100. Schuff N, Neylan TC, Fox-Bosetti S, et al. Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res 2008;162:147–57.
101. Eckart C, Kaufmann J, Kanowski M, et al. Magnetic resonance volumetry and spectroscopy of hippocampus and insula in relation to severe exposure of traumatic stress. Psychophysiology 2012;49:261–70.
102. Guo M, Liu T, Guo JC, Jiang XL, Chen F, Gao YS. Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac J Trop Med 2012;5:323–5.
103. Shu XJ, Xue L, Liu W, et al. More vulnerability of left than right hippocampal damage in right-handed patients with posttraumatic stress disorder. Psychiatry Res 2012;212:237–44.
104. Rosso IM, Weiner MR, Crowley DJ, Silveri MM, Rauch SL, Jensen JE. Insula and anterior cingulate GABA levels in posttraumatic stress disorder: preliminary findings using magnetic resonance spectroscopy. Depress Anxiety 2014;31:115–23.
105. Meyerhoff DJ, Mon A, Metzler T, Neylan TC. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep 2014;37:893–900.
106. Pennington DL, Abé C, Batki SL, Meyerhoff DJ. A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder. Psychiatry Res 2014;224:281–7.
107. Yang ZY, Quan H, Peng ZL, Zhong Y, Tan ZJ, Gong QY. Proton magnetic resonance spectroscopy revealed differences in the glutamate + glutamine/creatine ratio of the anterior cingulate cortex between healthy and pediatric post-traumatic stress disorder patients diagnosed after 2008Wenchuan earthquake. Psychiatry Clin Neurosci 2015;69:782–90.
108. Rosso IM, Crowley DJ, Silveri MM, Rauch SL, Jensen JE. Hippocampus glutamate and N-acetyl aspartate markers of excitotoxic neuronal compromise in posttraumatic stress disorder. Neuropyschopharmacology 2017;42:1698–705.
109. Moffet JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-acetylaspartate in the CNS: fromneurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89–131.
110. Rasmusson AM, Shi L, Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after reexposure to cues previously associated with footshock. Neuropyschopharmacology 2002;27:133–42.
111. Calvo DJ, González AN. Dynamic regulation of the GABAA receptor function by redoxmechanisms. Mol Pharmacol 2016; 90:326–33.
112. Isaacks R, Bender A, Kim C, Prieto N, Norenberg M. Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem Res 1994;19:331–8.
113. Zahr NM, Mayer D, Rohlfing T, Sullivan EV, Pfefferbaum A. Imaging neuroinflammation?A perspective from MR spectroscopy. Brain Pathol 2014;24:654–64.
114. Chang L, Munsaka SM, Kraft-Terry S, Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol 2013;8:576–93.
115. Cross NE, Lagopoulos J, Duffy SL, et al. Sleep quality in healthy older people: relationship with 1H magnetic resonance spectroscopy markers of glial and neuronal integrity. Behav Neurosci 2013;127:803–10.
116. Gu F, Chauhan V, Chauhan A. Glutathione redox imbalance in brain disorders. Curr Opin Clin Nutr Metab Care 2015;18: 89–95.
117. Duffy SL, Lagopoulos J, Cockayne N, et al. Oxidative stress and depressive symptoms in older adults: a magnetic resonance spectroscopy study. J Affect Disord 2015;180:29–35.
118. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002;287:3223–9.
119. Dumont M, Lin MT, Beal MF. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer’s disease. J Alzheimers Dis 2010;20:633–43.
120. Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA Cooperative Randomized Trial. JAMA 2014; 311:33–44.
121. Firuzi O, Miri R, Tavakkoli M, Saso L. Antioxidant therapy: current status and future prospects. Curr Med Chem 2011;18: 3871–88.
122. Reddy TP, Manczak M, Calkins MJ, et al. Toxicity of neurons treated with herbicides and neuroprotection by mitochondriatargeted antioxidant SS31. Int J Environ Res Public Health 2011;8:203–21.
123. Nałęcz KA, Miecz D, Berezowski V, Cecchelli R. Carnitine: transport and physiological functions in the brain. Mol Aspects Med 2004;25:551–67.
124. Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry 2000;5:616–32.
125. Ribas GS, Vargas CR, Wajner M. l-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 2014;533:469–76.
126. Unnithan AS, Jiang Y, Rumble JL, et al. N-acetyl cysteine prevents synergistic, severe toxicity from two hits of oxidative stress. Neurosci Lett 2014;560:71–6.
127. Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol 2016;20:357–66.
128. Monsey MS, Gerhard DM, Boyle LM, Briones MA, Seligsohn M, Schafe GE. A diet enriched with curcumin impairs newly acquired and reactivated fear memories. Neuropsychopharmacology 2015;40:1278–88.
129. Ebenezer PJ, Wilson CB, Wilson LD, Nair AR. The antiinflammatory effects of blueberries in an animal model of post-traumatic stress disorder (PTSD). PLoS One 2016;11: e0160923.
130. Higgins DM, Kerns RD, Brandt CA, et al. Persistent pain and comorbidity among Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn veterans. Pain Med 2014;15:782–90.
131. Wong JJ, Côté P, Sutton DA, et al. Clinical practice guidelines for the noninvasive management of low back pain: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain 2017;21: 201–16.
132. Molino S, Dossena M, Buonocore D, et al. Polyphenols in dementia: from molecular basis to clinical trials. Life Sci 2016; 161:69–77.
133. Davinelli S, Maes M, Corbi G, Zarrelli A, Willcox DC, Scapagnini G. Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges. Immun Ageing 2016;13:16.
134. Venigalla M, Sonego S, Gyengesi E, Sharman MJ, Münch G. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease. Neurochem Int 2016;95:63–74.
135. Bertram S, Brixius K, Brinkmann C. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients. Endocrine 2016;53: 350–63.
136. Svensson M, Lexell J, Deierborg T. Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings. Neurorehabil Neural Repair 2015;29:577–89.